110 related articles for article (PubMed ID: 892235)
1. Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice.
Tuman RW; Doisy RJ
Diabetes; 1977 Sep; 26(9):820-6. PubMed ID: 892235
[TBL] [Abstract][Full Text] [Related]
2. Glucose tolerance factor extracted from yeast: oral insulin-mimetic and insulin-potentiating agent: in vivo and in vitro studies.
Weksler-Zangen S; Mizrahi T; Raz I; Mirsky N
Br J Nutr; 2012 Sep; 108(5):875-82. PubMed ID: 22172158
[TBL] [Abstract][Full Text] [Related]
3. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics.
Uusitupa MI; Kumpulainen JT; Voutilainen E; Hersio K; Sarlund H; Pyörälä KP; Koivistoinen PE; Lehto JT
Am J Clin Nutr; 1983 Sep; 38(3):404-10. PubMed ID: 6351586
[TBL] [Abstract][Full Text] [Related]
4. The influence of age on the development of hypertriglyceridaemia and hypercholesterolaemia in genetically diabetic mice.
Tuman RW; Doisy RJ
Diabetologia; 1977 Jan; 13(1):7-11. PubMed ID: 838204
[TBL] [Abstract][Full Text] [Related]
5. Failure of glucose tolerance factor-containing Brewer's yeast to ameliorate spontaneous diabetes in C57BL/KsJ DB/DB mice.
Flatt PR; Juntti-Berggren L; Berggren PO; Gould BJ; Swanston-Flatt SK
Diabetes Res; 1989 Mar; 10(3):147-51. PubMed ID: 2680228
[TBL] [Abstract][Full Text] [Related]
6. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men.
Rabinowitz MB; Gonick HC; Levin SR; Davidson MB
Diabetes Care; 1983; 6(4):319-27. PubMed ID: 6352208
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects.
Offenbacher EG; Pi-Sunyer FX
Diabetes; 1980 Nov; 29(11):919-25. PubMed ID: 7000589
[TBL] [Abstract][Full Text] [Related]
8. Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice.
Tuman RW; Bilbo JT; Doisy RJ
Diabetes; 1978 Jan; 27(1):49-56. PubMed ID: 340311
[No Abstract] [Full Text] [Related]
9. Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats.
Kaufmann RL; Assal JPh ; Soeldner JS; Wilmshurst EG; Lemaire JR; Gleason RE; White P
Diabetes; 1975 Jul; 24(7):672-9. PubMed ID: 1158032
[TBL] [Abstract][Full Text] [Related]
10. Glucose tolerance factor reduces blood glucose and free fatty acids levels in diabetic rats.
Mirsky N
J Inorg Biochem; 1993 Feb; 49(2):123-8. PubMed ID: 8455018
[TBL] [Abstract][Full Text] [Related]
11. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
[TBL] [Abstract][Full Text] [Related]
12. Effects of diabetes mellitus on cholesterol metabolism in man.
Bennion LJ; Grundy SM
N Engl J Med; 1977 Jun; 296(24):1365-71. PubMed ID: 870827
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and immunoreactive insulin in relatives of diabetic patients.
Jakobson T
Isr J Med Sci; 1972 Jun; 8(6):831-2. PubMed ID: 5051810
[No Abstract] [Full Text] [Related]
14. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium.
Rink C; Roy S; Khanna S; Rink T; Bagchi D; Sen CK
Physiol Genomics; 2006 Nov; 27(3):370-9. PubMed ID: 16940432
[TBL] [Abstract][Full Text] [Related]
16. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism.
Chen G; Liu P; Pattar GR; Tackett L; Bhonagiri P; Strawbridge AB; Elmendorf JS
Mol Endocrinol; 2006 Apr; 20(4):857-70. PubMed ID: 16339278
[TBL] [Abstract][Full Text] [Related]
17. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of diabetic nephropathy in rats by an oral antidiabetic material extracted from yeast.
Nakhoul F; Abassi Z; Morgan M; Sussan S; Mirsky N
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S127-31. PubMed ID: 16565236
[TBL] [Abstract][Full Text] [Related]
20. The effect of a saccharose-rich diet on carbohydrate and lipid metabolism of streptozotocin-diabetic rats and genetically determined 'diabetic' mice (gg-diab).
Gonnermann B; Schäfer-Spiegel R; Laube H; Schatz H
Int J Obes; 1982; 6 Suppl 1():41-8. PubMed ID: 6214518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
